Acute myeloid leukaemia (AML) cells express the SCF receptor c-kit (CD117) on their cell surface and demonstrate enhanced adhesion to fibronectin (FN) following exposure to stem cell factor (SCF). Increased adhesion occurs within 5 min, is dose dependent, and persists beyond 2 h. Baseline and enhanced adhesion occur through the surface FN receptor very late antigen-5 (VLA-5, CD49e/CD29) which is expressed by AML cells. Unstimulated AML cells exposed to FN undergo less apoptosis than controls (inhibition 22.5 ± 7.0%, P = 0.02, n = 8). Exposure to SCF alone without FN also inhibits AML cell apoptosis (by 19.0 ± 7.7% compared to controls, P = 0.06, n = 8). Simultaneous exposure to SCF and FN increases the inhibition of AML cell apoptosis to 37.8 ± 7.9% (P = 0.005 compared to control, P = 0.04 compared to FN alone, P = 0.06 compared to SCF alone) demonstrating that SCF not only enhances the propensity of AML cells to adhere to FN, but also results in an additive survival benefit following FN contact. Some but not all the reduction in apoptosis is mediated through VLA-5. The combination of SCF and FN also affects proliferation, resulting in a synergistic enhancement of AML cell proliferation in half the cases studied. When normal CD34
Introduction
Interaction between the bone marrow stroma (BMS) and developing human progenitor cells (HPCs) is important for the maintenance and regulation of normal and malignant haemopoiesis. [1] [2] [3] In part, this is due to stromal secretion of soluble factors acting on stem cells and committed progenitors. 4, 5 However, soluble factors released from stromal cells do not consistently reproduce the effects of a stromal cell layer on haemopoietic progenitors in culture. 6, 7 Blast cells from a proportion of cases of both acute myeloid (AML) and acute lymphoblastic leukaemia (ALL) grow in culture on stromal monolayers, but rarely grow for equivalent periods in stromalconditioned medium 8, 9 suggesting that additional contactdependent factors are important. We have previously shown that direct contact with stromal layers inhibits the apoptosis and preserves the viability of clonogenic leukemic cells, 10, 11 underlining the importance of contact itself on processes such as cell growth, maturation and survival. Mechanisms of leukaemic cell/stromal contact are complex but are recognised Correspondence: DJ Gottlieb; Fax: 612 9687 2331 Received 8 August 1997; accepted 3 June 1998 to involve at least the ␤-1 integrin receptors very late antigen-4 (VLA-4) and VLA-5 in the majority of ALL cells 12, 13 and VLA-4 and VLA-5 in combination with the ␤-2 integrin LFA-1 in cases of AML.
Integrin engagement induces cellular kinase activation, cytoskeletal protein accumulation and second messenger production. The resulting alterations affect cell motility, proliferation and survival. 14, 15 In haemopoietic cells, fibronectin receptor engagement has been reported to inhibit proliferation and induce apoptosis, 16, 17 while blockade of fibronectin receptors inhibits lymphocyte migration and erythropoietic development in utero. 18, 19 However, in vivo, changes to the status of fibronectin receptors are unlikely to occur in isolation. HPCs in the bone marrow microenvironment meet not only high concentrations of fibronectin but many other stromal ligands and stromal-associated growth factors. Recent work indicates that crosstalk between cytokine and stromal receptors on HPCs results in cytokine exposure being accompanied by enhanced adhesion to fibronectin. 20 The effect of fibronectin itself on the behaviour of normal and malignant myeloid cells has not been extensively studied. Contact with fibronectin reduces proliferation of normal myeloid progenitor cells. 16 In this work, we have analysed the effect of fibronectin on acute myeloid leukaemia cell growth and survival and studied the outcome of the interaction of stem cell factor (SCF) and fibronectin on acute myeloid leukaemia cells. SCF was studied because of its wide expression in both transmembrane and soluble form on BMFs within the bone marrow. As a transmembrane protein it acts directly as an adhesion molecule involved in AML cell localisation to the bone marrow stroma. 21, 22 AML cells frequently express both VLA-5 and the SCF receptor c-kit and are likely to bind both ligands within the bone marrow. Our data show that SCF enhances the anti-apoptotic and proliferative effects of fibronectin on acute myeloid leukaemia cells and promotes leukemic cell survival.
Materials and methods

Cells
AML blasts were isolated as previously described from peripheral blood or bone marrow samples obtained from patients for diagnostic purposes. 12 The final blast purity was 92 ± SE 1%. Patient details are given in Table 1 . Institutional ethics committee approval was given and informed consent obtained prior to sample collection. CD34 + cells were isolated from normal bone marrow samples obtained from allogeneic bone marrow donors. The mononuclear fraction was isolated on Ficoll-Hypaque (Pharmacia, Uppsala, Sweden) and washed twice with phosphate-buffered saline containing DNase (PBS/DNase). Cells were labelled with biotinylated QBEND10 (Prof M Greaves, 
Adhesion assays
Adhesion assays were performed as previously described except that serum-free AIMV medium (Cytosystems, Sydney, NSW, Australia) was used throughout. 12 Briefly, cells were labelled with sodium 51 chromate for 90 min at 37°C and washed twice prior to plating into microtitre wells. Plates were coated overnight at 4°C with 10 g/ml of fibronectin in PBS (Telios, San Diego, CA, USA). Following two washes with PBS remaining sites were blocked with 1% BSA for 2 h at 37°C and excess BSA removed by washing. Where indicated cells were treated with antibodies to adhesion molecules for 30 min at 4°C and/or SCF at indicated concentrations was added to cells prior to plating. Following plating, cells were sedimented at 150 g for 3 min then incubated at 37°C for 1 h unless otherwise indicated. Non-adherent cells were removed by two washes, the adherent cells lysed with 2% Triton X-100 and the lysate counted in a gamma counter. For the time course experiment SCF (5 U/ml) was added to AML blasts (case No. 7) in serum-free medium at various time points and the cells incubated at 37°C until plating on to immobilised fibronectin in pre-warmed microtitre plates. Cells were sedimented for 2 min at 150 g and incubated for a further 3 min at 37°C. Blocking antibodies to adhesion molecules were anti-␤-1 integrin chain, 4B4 (Coulter Clones, Hialeah, FL, USA); anti-␣5 integrin chain, PHM2 (Silenus, Hawthorn, Victoria, Australia) or PID6 (Dutec; Telios) and anti-␣-4 integrin chain, HP2/1 (Haem, Melbourne, Victoria, Australia). Adhesion to BSAcoated wells was always less than 10% of the input cells and this value was subtracted from the total percentage adhesion to determine the percentage of cells which specifically bound to the test substrate.
Tissue culture, apoptosis and proliferation
AML blasts or CD34
+ cells were plated at 5 × 10 4 cells/well in 200 l of AIMV medium and cultured for 72 h in a humidified incubator containing 5% CO 2 . The following were added at the initiation of culture where indicated: fibronectin (50 g/ml), SCF (5 U/ml) and/or PHM2 or PID6 (5 g/ml). Aopotosis was quantified by flow cytometry as previously described. 11 Briefly, cells were washed in PBS, fixed in 80% ethanol at 4°C for 30 min and stained in PBS containing EDTA (0.1 mM), Triton X-100 (0.1% w/v), RNase A (50 g/ml) and propidium iodide (50 g/ml). After 1 h at room temperature in the dark, cells were analysed on a FACScan flow cytometer. Cells falling into a sub-G0/G1 peak were enumerated and considered to be apoptotic.
Cell proliferation was determined using 3 H-thymidine assays. Cells were incubated with 3 H-thymidine (20 Ci) (Amersham, Bucks, UK) for 4 h at 37°C, harvested on to filters (ICN; Sydney, Australia) and incorporated 3 H-thymidine detected in a scintillation counter using Ecolite scintillant (ICN).
Soluble fibronectin was used for these studies because it had been previously reported to be more effective at inducing apoptosis than immobilised fibronectin. 17 We also found the effect of soluble fibronectin on cell adhesion and proliferation was more pronounced than that of immobilised fibronectin.
Statistics
Statistical significance within experiments was calculated using the Student's t-test. Data from multiple cases were analysed by calculating the difference from control, reducing the data for repeat tests then using the paired t-test.
Results
Base line and SCF-induced adhesion of AML blasts to fibronectin
AML blast cells have previously been shown to adhere to immobilised fibronectin. 23 In blocking studies using antibodies to the ␣-5 and ␤-1 integrin chains or in the presence of the chelating agent EDTA, we demonstrated that virtually all AML cell binding to fibronectin occurs through the ␤-1
Figure 1
Mechanism of adhesion of AML cells to immobilised fibronectin. AML cells were studied in adhesion assays as described in Materials and methods. Cells were incubated on immobilised fibronectin in the presence of antibodies to ␤-1 integrin, ␣-4 integrin, ␣-5 integrin or combination as shown. Inhibition of adhesion was calculated by comparison with adhesion to fibronectin in the presence of an isotype-matched control antibody.
integrin VLA-5 ( Figure 1 ). The possibility that SCF binding to c-kit (CD117) expressed on the surface of AML cells would increase adhesion to fibronectin was examined. SCF augmented the adhesion of AML blasts to fibronectin at all time points tested from 5 min to 2 h (Figure 2 ). The upregulation of adhesion of AML blasts is dose dependent (case No. 1)
Figure 2
Time course of the effect of SCF on the adhesion of AML blasts (case No. 2) to fibronectin. Adhesion of AML blasts was determined following exposure to 5 U/ml of SCF for the indicated time points. Times indicated include the time from the addition of SCF to AML blasts in solution, plating, centrifugation for 2 min and incubation at 37°C for 3 min prior to removal of non-adherent cells. Percentage adhesion is shown (mean of triplicate determinations). Bars indicate standard errors.
( Figure 3 ). Four cases were examined following 2 h stimulation with 2.5 U/ml SCF and an increase in adhesion in response to SCF was observed in every case. The mean adhesion increased from 11.8 ± SE 2.5% to 18.4 ± SE 3.4% (P = 0.024) with even this modest dose of SCF. In subsequent experiments SCF was used at a concentration of 5 U/ml. No increase in adhesion could be detected following the addition of SCF if laminin was used in place of fibronectin demonstrating that the effect was specific. SCF also failed to augment the adhesion of AML cells to BMF monolayers in four separate experiments (data not shown).
Mechanism of increased adhesion to fibronectin
The mechanism of SCF-enhanced binding to fibronectin was examined in six cases (Nos 2, 3, 6, 7, 9 and 10). Results from four cases are given in Figure 4 . SCF did not induce any consistent change in the surface expression of VLA-5 (results not shown). Cells were incubated with antibodies to ␣-5 or ␤-1 prior to plating on immobilised fibronectin in the presence or absence of 5 U/ml of SCF. Adhesion was assessed following a 1 h incubation. Adhesion of AML blasts to fibronectin could be inhibited using antibodies to ␤-1 or ␣-5 indicating that AML blasts bind to fibronectin via the ␤-1 integrin VLA-5. Antibody to the VLA-4 ␣-chain had no significant effect on adhesion. Adhesion of SCF-stimulated AML cells in the presence of antibody to ␣-5 was equivalent to that of untreated cells, indicating that VLA-5 was responsible for the upregulation in adhesion of AML blasts to fibronectin following stimulation with SCF.
Effect of fibronectin and SCF on AML cell proliferation and apoptosis
Fibronectin has been reported to reduce the proliferation of leukemic cell lines and to induce programmed cell death through VLA-5. 17 We incubated fresh human AML blast cells with fibronectin and compared their rate of apoptosis and proliferative response with cells cultured in serum-free medium alone. In contrast to the data reported for leukemic cell lines, we found that soluble fibronectin inhibited apoptosis of blast cells in most cases of AML. Baseline apoptosis in blast cells ranged from 26 to 94% over the 72 h culture period. A similar effect was observed after 24 h and 6 days of culture ( Figure  5 ). For all cases, the mean percentage inhibition of apoptosis during the culture period was 22.8 ± 11.0 for cells incubated with fibronectin compared with control, n = 8, P = 0.014. DNA histograms from a representative case are shown in Figure 6 . Where sufficient cells were available samples were analysed in duplicate. This revealed that fibronectin significantly inhibited apoptosis in four of six cases (Table 2 ). In these four cases, antibody to VLA-5 was found to reverse the effect in two cases while antibody to VLA-4 had only a partial effect in one case (No. 8). When data from all eight cases were combined, the presence of fibronectin and a blocking antibody to the chain of VLA-5 was found to be completely effective in some cases but not in all (mean percentage inhibition of apoptosis 1.0 ± 10.9, P = 0.005 compared to fibronectin alone), while antibody to VLA-4 was less effective (mean percentage inhibition of apoptosis 14.7 ± 4.4, P = 0.05 compared to fibronectin alone). SCF alone induced significant inhibition of apoptosis of AML cells in two of six cases and the mean inhibition for all eight cases of 17.5 ± 12.0 was not statistically significant compared to control. The combination of SCF and fibronectin was more effective than either cytokine alone in four of six cases. Mean inhibition for all eight cases was 38.8 ± 10.0% (P = 0.008 compared to control, P = 0.036 compared to fibronectin alone). The enhanced inhibition of apoptosis was only partially mediated through VLA-5 (addition of an anti-␣-5 antibody to the combination of fibronectin and SCF induced mean inhibition of apoptosis of 20.6 ± 10.3%, P = 0.046 compared to fibronectin + SCF).
In separate experiments studying the apoptosis of normal CD34
+ cells, SCF also reduced apoptosis (see Table 3 ). The effect of fibronectin, however, was minor and the combi- Time course of the effect of fibronectin and stem cell factor on apoptosis and proliferation in two cases of AML. AML blasts were cultured in either medium alone, fibronectin, SCF or a combination of fibronectin and SCF. Cells were harvested after 1, 3 and 6 days and the percentage of apoptotic cells determined by flow cytometry and the proliferative rate determined by tritiated thymidine incorporation. Each panel shows results from days 1 (left), 3 (centre) and 6 (right). Case numbers are shown in the upper right hand corner of each panel.
nation did not appear more effective than SCF alone. Similar experiments were carried out to analyse the role of SCF and fibronectin on cellular proliferation. The effect of fibronectin on proliferation of AML cells was not consistent. In one of six cases, a two-fold or greater increase in proliferation was observed with cell culture in fibronectin (Table 4) . SCF induced a two-fold or greater increase in proliferation in four of the six cases and in three of these, the combination of SCF and fibronectin had a synergistic effect occurring through VLA-4, VLA-5 and through other not identified surface receptors. A similar result was noted for normal CD34 + cells (Table 3 ).
Discussion
The physiological events which follow adhesion between developing haemopoietic progenitor cells and the bone marrow microenvironment are poorly understood. The data presented here indicate that exposure of AML cells to SCF enhances their adhesion to the extracellular matrix protein fibronectin which is found in high concentration within the bone marrow. The increased adhesion is due entirely to binding occurring through the ␤-1 integrin VLA-5, a process previously described by Dastych and Metcalfe 24 for mast cells binding to fibronectin and also described in normal CD34 + progenitor cells. 25 Inhibition of apoptosis of AML blasts by soluble fibronectin and SCF. AML blasts were cultured in either medium alone (a), or in the presence of soluble fibronectin (b), SCF (c) or a combination of fibronectin and SCF (d). Cells were harvested after 72 h in culture and the percentage of apoptotic cells determined by flow cytometry.
SCF-induced increases in adhesion
Table 2
Effect of FN and SCF on the percentage of apoptotic AML blasts in culture
2 8± 3* 31 ± 1* 30 ± 4 3 9 ± 1** 36 ± 0 3 4 ± 1 3 4 ± 2 2 7 2 ± 4 5 2± 4* 52 ± 2* 47 ± 1* 51 ± 6* 40 ± 1* 55 ± 8* 48 ± 1* 5 9 4 ± 0 7 4± 6* 83 ± 4 6 4± 4* 67 ± 2 6 8 ± 3 7 3 ± 4 7 0 ± 9 7 5 0 ± 1 4 8± 2 4 3± 1
AML blasts were incubated for 72 h under the indicated conditions prior to being assessed for apoptosis. Figures show percentage apoptotic cells calculated as described in Materials and methods. *P Ͻ 0.05 compared to control, **P Ͻ 0.05 compared to fibronectin-treated cells. + ␣4 indicates the presence of antibody HP2/1 to ␣4 integrin chain (CD49d). + ␣5 indicates the presence of PHM2 or PID6 antibody to ␣5 integrin chain (CD49e). occurred in all cases studied with a rapid onset at 5 min. Dose-response studies found no plateau in the adhesion response at the maximum dose tested of 50 U/ml when the adhesion was over four-fold control. In contrast to the effect on mast cells, which showed only a transient response, the response observed in AML blasts persisted up to and beyond 2 h. Haemopoietic progenitors may bind to stromal fibroblasts expressing transmembrane SCF through the SCF receptor c-kit expressed on the cell surface. This direct interaction would then be followed by the subsequent upregulation of adhesion to fibronectin containing environments through VLA-5. Loss of c-kit, which occurs with normal myeloid maturation, may weaken the stromal interaction by both robbing the cell of an independent adhesion ligand and reducing the augmented binding through VLA-5. To et al 26 have noted that one of the few immunophenotypic differences between bone marrow and mobilised peripheral blood stem cells is that the peripheral blood stem cells express significantly less c-kit than their bone marrow counterparts, suggesting that peripheral blood stem cell recruitment may occur through circulation of a population of progenitors with weaker adhesion to bone marrow stroma.
The effects of fibronectin on human progenitor cells are not well established. In one study by Sugahara et al, 17 fibronectin reduced the proliferation and enhanced the rate of programmed cell death of a wide range of VLA-5 expressing leukemic cell lines. Despite reproducing the experimental methods, we obtained contrasting results for fresh human myeloid leukaemic cells which responded to fibronectin with reduced apoptosis and in some cases, enhanced proliferation, effects which were mediated partially through the fibronectin receptor VLA-5. In addition to its effect on adhesion, SCF enhanced the anti-apoptotic effect of fibronectin in an additive way and the proliferative effect synergistically in some but not all cases. In normal, high purity, CD34
+ cells a similar effect was observed although fibronectin alone had little antiapoptotic effect. These data support our previous experimental observation that leukemic blast cells separated from the stroma survive less well than those remaining in stromal contact because separation induces apoptotic death in the leukemic blasts. SCF and fibronectin, both in high concentration in the stroma, inhibit leukaemia apoptosis and probably contribute significantly to the inhibition of apoptosis produced by stromal contact. Clearly, other factors are also important. We cannot simply explain the lack of concordance between our results and those previously published except to note that in the experiments of Sugahara et al leukemic cell lines rather than fresh cells were used. The inherent abnormalities involved in autonomous proliferation may alter responses to external stimuli such as cytokines and matrix proteins.
These data underline the relationship between cytokine and adhesion receptors which has recently been observed in normal human CD34 + cells. 25 The activation status of adhesion receptors is altered by cytokine exposure and correlates with the proliferation status of the cells. This inside out signalling occurs in myeloid leukemia cells as well as normal CD34 + cells after exposure to SCF and other physiologic cytokines. Adhesion receptors activated following cytokine exposure may subsequently mediate outside in signals which further modulate cell survival and growth. These data may help to explain the apparent redundancy of fibronectin receptors on the surface of many cell types including AML cells. The diversity could reflect the roles of particular receptors in signal transduction mediating particular cell processes. Crosstalk between adhesion and growth factor receptors may be prominent determinants of haemopoietic progenitor cell behaviour.
